Prepared Remarks:

Operator

Ladies and gentlemen, good morning, and welcome to the CVS Health third-quarter 2022 earnings conference call. [Operator instructions] As a reminder, today's conference is being recorded. I would now like to turn the call over to Larry McGrath, senior vice president of business development and investor relations for CVS Health. Please go ahead.

Larry McGrath -- Senior Vice President, Business Development and Investor Relations

Good morning, and welcome to the CVS Health third-quarter 2022 earnings call and webcast. I'm Larry McGrath, senior vice president of business development and investor relations for CVS Health. I'm joined this morning by Karen Lynch, president and chief executive officer; and Shawn Guertin, executive vice president and chief financial officer. Following our prepared remarks, we'll host a question-and-answer session that will include Dr.

Alan Lotvin, president, pharmacy services; Daniel Finke, president healthcare benefits; Michelle Peluso, chief customer officer and retail co-president; and Prem Shah, chief pharmacy officer and retail co-president. Our press release and slide presentation have been posted to our website, along with our Form 10-Q that we filed this morning with the SEC. Today's call is being broadcast on our website, where it will be archived for one year. During this call, we will make certain forward-looking statements, reflecting current views related to our future financial performance, future events, industry, and market conditions, including impacts related to the ongoing COVID-19 pandemic, as well as the expected consumer benefits of our products and services, and our financial projections, and the benefits of the proposed acquisition of Signify Health, Inc., and the associated integration plan, expected synergies, and revenue opportunities.

Our forward-looking statements are subject to significant risks and uncertainties that could cause actual results to differ materially from currently projected results, including with respect to the ongoing COVID-19 pandemic, and the proposed acquisition and the integration of Signify Health. We strongly encourage you to review the reports we file with the SEC regarding these risks and uncertainties, including our most recent annual reports on Form 10-K, our recent current reports on Form 8-K, this morning's earnings press release, and our Form 10-Q. During this call, we will use non-GAAP measures when talking about the company's performance and financial conditions, and you can find a reconciliation of these non-GAAP measures in this morning's press release and in the reconciliation document posted to the investor relations portion of our website. With that, I'd like to turn the call over to Karen.